TERNS PHARMACEUTICALS INC (TERN) Stock Balance Sheet
NASDAQ:TERN - Nasdaq - US8808811074 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 28.72M | 13.87M | 46.14M | 120.20M | 14.50M | |||
| Cash Equivalents | 110.31M | 147.57M | 33.79M | 23.00M | 33.20M | |||
| Marketable Securities | 195.24M | 196.72M | 183.51M | 139.90M | 118.30M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 3.48M | 3.94M | 3.99M | 2.10M | 900.00K | |||
| Total Current Assets | 337.75M | 362.11M | 267.43M | 285.20M | 166.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.22M | 1.47M | 1.03M | 1.80M | 1.00M | |||
| Other Non-Current Assets | 351.00K | 350.00K | 56.00K | 0.00 | 100.00K | |||
| Total Non-Current Assets | 1.57M | 1.82M | 1.08M | 1.80M | 1.20M | |||
| TOTAL ASSETS | 339.31M | 363.93M | 268.52M | 287.00M | 168.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.58M | 13.05M | 9.15M | 6.60M | 4.30M | |||
| Accounts Payable | 2.78M | 2.15M | 2.52M | 1.60M | 2.10M | |||
| Other Current Liabilities | 580.00K | 455.00K | 278.00K | 200.00K | 400.00K | |||
| Total Current Liabilities | 10.94M | 15.65M | 11.94M | 8.50M | 6.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.34M | 2.41M | 1.21M | 1.60M | 900.00K | |||
| Total Non-Current Liabilities | 2.34M | 2.41M | 1.21M | 1.60M | 1.00M | |||
| TOTAL LIABILITIES | 13.27M | 18.06M | 13.15M | 10.10M | 7.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -445.39M | -421.48M | -332.63M | -242.40M | -182.10M | |||
| Additional Paid In Capital | 771.37M | 767.62M | 588.01M | 520.20M | 342.70M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 9.00K | 9.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 51.00K | -279.00K | -19.00K | -800.00K | -300.00K | |||
| Shares Outstanding | 87.30M | 87.13M | 64.58M | 53.70M | 25.30M | |||
| Tangible Book Value per Share | 3.73 | 3.97 | 3.95 | 5.16 | 6.34 | |||
| Total Shareholders' Equity | 326.04M | 345.87M | 255.37M | 276.90M | 160.30M | |||
| TOTAL LIABILITIES AND EQUITY | 339.31M | 363.93M | 268.52M | 287.00M | 168.10M | |||
| Statistics | ||||||||
| Current Ratio | 30.89 | 23.14 | 22.39 | 33.55 | 24.54 | |||
| Return On Assets (ROA) | -26.64% | -24.41% | -33.60% | -21.03% | -29.84% | |||
| Return On Equity (ROE) | -27.72% | -25.69% | -35.33% | -21.79% | -31.29% | |||
All data in USD , ROIC based on taxRate of 0.21